Victor Pikov is a co-founder and CEO of Medipace Inc, a startup developing implantable neuromodulation therapies for auto-immune intestinal diseases. Prior to that, for three years Victor worked at Galvani Bioelectronics and GlaxoSmithKline, where he oversaw development and testing of implantable pulse generators and stimulation leads (nerve cuffs and percutaneous electrodes) for several clinical applications, including auto-immune and metabolic diseases. Victor has several patent applications for implantable neuromodulation therapies and a non-invasive glucose measurement device.